share_log

Foresight Acquisition M&A Partner P3 Health Partners Announces Expansion Into California Managed Care Market

Foresight Acquisition M&A Partner P3 Health Partners Announces Expansion Into California Managed Care Market

Foresight收購併購合作伙伴P3 Health Partners宣佈進軍加州管理保健市場
Benzinga Real-time News ·  2021/11/11 12:38

P3 Health Partners ("P3" or the "Company"), a patient-centered and physician-led population health management company, today announced the Company's expansion into California's Central Valley through its acquisition of Medcore HP ("MHP"), a health plan licensed under the California Knox-Keene Health Care Service Plan Act of 1975, and Omni IPA Medical Group, Inc. ("Omni"), an independent practice association in San Joaquin County, California. P3 brings its proven talent, tools and technology to help providers deliver high-quality, cost-effective care to patients in the Central Valley.
 

亞洲網加利福尼亞州聖華金縣3月16日電以患者為中心、以醫生為主導的人口健康管理公司P3 Health Partners(簡稱“P3”或“公司”)今天宣佈,公司通過收購Medcore HP(“MHP”)和Omni IPA Medical Group,Inc.(“Omni”)向加州中央山谷擴張。Medcore HP(“MHP”)是根據1975年“加州諾克斯-基恩健康護理服務計劃法案”(California Knox-Keene Health Care Service Plan Act)獲得許可的健康計劃,Omni是加利福尼亞州聖華金縣的一個獨立執業協會。P3帶來了其成熟的人才、工具和技術,幫助提供者向中央山谷的患者提供高質量、高成本效益的護理。

The transaction is expected to close by the end of the year but remains subject to regulatory approval and other customary closing conditions.

這筆交易預計將在今年年底前完成,但仍有待監管部門的批准和其他慣常的完成條件。

Following the close of the transaction, P3 will have access to Medcore HP's restricted Knox Keene license, which will allow it to take global risk from other health plans and grow into additional markets while increasing the Company's access to patients, physicians, hospitals, and payers. MHP contracts directly with major health plans in California and its health plan license allows it to take global risk on more than 10,500 Medicare Advantage members in San Joaquin County. With some of the largest healthcare network in the United States, California represents an opportunity for P3 to grow its membership and bring its expertise in improving outcomes while reducing costs to California's Central Valley and beyond.

交易完成後,P3將獲得Medcore HP的受限Knox Keene許可證,這將使它能夠從其他健康計劃中承擔全球風險,並在擴大公司接觸患者、醫生、醫院和付款人的機會的同時,進入更多的市場。MHP直接與加利福尼亞州的主要醫療計劃簽訂合同,其醫療計劃許可證允許其在聖華金縣為10,500多名Medicare Advantage會員承擔全球風險。加利福尼亞州擁有美國一些最大的醫療保健網絡,為P3提供了一個機會,可以擴大其會員規模,並將其在改善結果方面的專業知識帶到加州中央山谷和其他地區,同時降低成本。

Omni is an independent practice association with over 400 contracted physicians and other health care providers currently contracted under MHP's provider network. The addition of these healthcare providers offers P3 increased ease of integration into the service area and a built-in provider footprint. P3 also looks forward to leveraging the strong leadership and deep in-market experience Omni brings, which is well suited to enhance the current offering while providing efficacy at scale within the value-based model.

OMNI是一個獨立的執業協會,目前有400多名簽約醫生和其他醫療保健提供者在MHP的提供者網絡下籤約。這些醫療保健提供商的加入提高了P3集成到服務領域的簡易性,並提供了內置的提供商足跡。P3還期待着利用OMNI帶來的強大領導力和深厚的市場經驗,這非常適合增強當前的產品,同時在基於價值的模式中提供規模化的效率。

"Medcore HP and Omni IPA Medical Group are natural additions to the P3 network of physicians and coverage, and more importantly, share our mission and vision to transform the way we approach healthcare," said Sherif Abdou, M.D., CEO of P3. "We believe value-based care is the future of medicine, and we are focusing our efforts to improve the efficacy of the healthcare system for providers while driving positive outcomes for patients. Expanding coverage to patients in California is a significant step for P3 and demonstrates our continued commitment to transforming healthcare."

P3公司首席執行官謝裏夫·阿布杜説:“Medcore HP和Omni IPA醫療集團是P3醫生網絡和覆蓋範圍的自然補充,更重要的是,它們分享了我們改變醫療保健方式的使命和願景。我們相信基於價值的護理是醫學的未來,我們正在集中努力提高醫療保健系統對提供者的功效,同時為患者帶來積極的結果。將覆蓋範圍擴大到加州的患者是P3邁出的重要一步,表明我們繼續致力於改變醫療保健。“

P3 announced earlier this year that it expects to become a public company via a merger with special purpose acquisition company, Foresight Acquisition Corp. (NASDAQ:FORE) ("Foresight").

P3今年早些時候宣佈,它預計將通過與特殊目的收購公司Foresight Acquisition Corp.(納斯達克:FORE)合併成為上市公司。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論